Status:

COMPLETED

Role of Soy Supplementation in Prostate Cancer Development

Lead Sponsor:

VA Office of Research and Development

Conditions:

Prostate Neoplasm

Eligibility:

MALE

18+ years

Phase:

PHASE3

Brief Summary

This is a randomized study evaluating the effectiveness and direct effect a commercial soy supplement has on prostate cancer and normal prostate tissue. Patient will be randomized it either receive pl...

Detailed Description

This is a randomized study evaluating the effectiveness and direct effect a commercial soy supplement has on prostate cancer and normal prostate tissue. Patients will be randomized to either receive p...

Eligibility Criteria

Inclusion

  • Histologically proven prostate cancer.
  • Surgical candidate for prostatectomy.
  • During study period, must agree not to take new supplements.
  • No concurrent chemotherapy, radiation or hormonal therapy.
  • No history of prior allergy to soy based products.
  • Must not have been taking soy supplements or soy isoflavones within 90 days prior to study enrollment.
  • Must be able to safely be on study supplements for period of at least two weeks prior to scheduled prostatectomy.
  • Must give written and informed consent in accordance with institutional and federal guidelines.

Exclusion

  • During study period, must agree not to take new supplements.
  • No concurrent chemotherapy, radiation or hormonal therapy.
  • No history of prior allergy to soy based products.
  • Must not have been taking soy supplements or soy isoflavones within 90 days prior to study enrollment.
  • Must be able to safely be on study supplements for period of at least two weeks prior to scheduled

Key Trial Info

Start Date :

September 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2009

Estimated Enrollment :

86 Patients enrolled

Trial Details

Trial ID

NCT00255125

Start Date

September 1 2005

End Date

October 1 2009

Last Update

June 18 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

VA Medical Center, Kansas City MO

Kansas City, Missouri, United States, 64128